Major Depressive Disorder (MDD) Study in Elderly Outpatients
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
560
Change from baseline to the week 10 last observation carried forward endpoint in the 17-item HAM-D total score.
Time frame: 10 Weeks
Mean change from baseline in HAM-D item 1; Mean change from baseline in the CGI severity of illness score at study endpoint; Percentage of patients with HAM-D total score less than or equal to 7.
Time frame: 10 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
GSK Investigational Site
Little Rock, Arkansas, United States
GSK Investigational Site
Anaheim, California, United States
GSK Investigational Site
Beverly Hills, California, United States
GSK Investigational Site
El Centro, California, United States
GSK Investigational Site
Los Angeles, California, United States
GSK Investigational Site
Redlands, California, United States
GSK Investigational Site
Santa Ana, California, United States
GSK Investigational Site
Colorado Springs, Colorado, United States
GSK Investigational Site
Norwich, Connecticut, United States
GSK Investigational Site
Jacksonville, Florida, United States
...and 36 more locations